News Conference News TCT 2013 Innovation in Intervention: Perspectives from Industry October 30, 2013
Presentation Cost-Effectiveness of Apixaban, Dabigatran, Rivaroxaban, and Warfarin for Stroke Prevention in Atrial Fibrillation Presenter: A.R. Harrington April 05, 2013
News Conference News ESC 2012 Study Looks at Global Mortality, Stroke Rates in A-fib Patients After ER Visit Yael L. Maxwell August 29, 2012
News Daily News Apixaban Less Costly Than Aspirin for Stroke Prevention in A-Fib at 10 Years Caitlin E. Cox July 12, 2012
News Daily News A los 10 Años el Apixaban resulta Más Barato que la Aspirina para la Prevención de ACV en Pacientes con FA Caitlin E. Cox July 12, 2012
News Daily News Live Case Procedures Just as Safe as in Daily Practice Caitlin E. Cox February 21, 2012
News Daily News Dabigatran Cost-Effective Only for A-Fib Patients at High Stroke Risk L.A. McKeown June 03, 2011
News Conference News PARTNER: TAVI Cost Effective Compared With Standard Care Jason Kahn April 03, 2011